research opportunities for residents - Weill Cornell Department of ...
research opportunities for residents - Weill Cornell Department of ...
research opportunities for residents - Weill Cornell Department of ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
My areas <strong>of</strong> clinical <strong>research</strong> interest, in association with the AIDS Clinical Trials Group, are in HIV<br />
infection in women and perinatal HIV infection.<br />
Recent Residents Mentored: Ritu Pati (currently ID fellow at <strong>Weill</strong> <strong>Cornell</strong>), Sabena Ramsetty (currently<br />
ID fellow at University <strong>of</strong> Virginia)<br />
Thomas J. Walsh, MD<br />
Pr<strong>of</strong>essor <strong>of</strong> Medicine<br />
Director, Transplantation/Oncology Infectious Diseases Program<br />
Email: thw2003@med.cornell.edu <br />
Tel: (212) 746-6320<br />
The mission <strong>of</strong> the Transplantation/Oncology Infectious Diseases Program is to develop new strategies<br />
<strong>for</strong> diagnosis, treatment, and prevention <strong>of</strong> life-threatening infections in immunocompromised<br />
patients. We accomplish this mission through translational laboratory and clinical <strong>research</strong> focusing on<br />
(1) antimicrobial pharmacology; (2) augmentation <strong>of</strong> innate host defenses; (3) molecular detection <strong>of</strong><br />
emerging pathogens. The advances achieved through laboratory investigations are translated through<br />
carefully designed clinical protocols in hematopoietic stem cell transplant recipients, solid organ<br />
transplant recipients, and patients with hematological malignancies.<br />
Timothy Wilkin, MD, MPH<br />
Associate Pr<strong>of</strong>essor <strong>of</strong> Medicine<br />
Email: tiw2001@med.cornell.edu<br />
Tel: (212) 746-7202<br />
Research interests are in the epidemiology and treatment <strong>of</strong> human papillomavirus (HPV) related anal<br />
dysplasia in HIV-infected men and women. Ongoing and planned projects include determining the<br />
predictors <strong>of</strong> persistent anal infection with HPV, describing outcomes <strong>for</strong> patients treated <strong>for</strong> high-grade<br />
anal intraepithelial neoplasia (HGAIN) and topical therapies <strong>for</strong> HGAIN.<br />
30